当前位置： SCI文献检索 > ONCOGENE期刊下所有文献 > Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer.

Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer.

Abstract：

:Colon cancer is the third leading cause of death from cancer worldwide with less than 10% survival rate at the late stage. Although mutations of certain genes have been implicated in familial colon cancer development, the etiology of the majority of colon cancer remains unknown. Herein, we identified TYRO3 as a potential oncogene. Immunohistochemical staining results demonstrated that levels of TYRO3 were markedly elevated in polyps and colon cancer cells and were negatively correlated with prognosis. Overexpression of TYRO3 enhanced cell motility, invasion, anchorage-independent growth and metastatic ability, while knockdown of TYRO3 impaired all these processes. Results from meta-analysis showed that TYRO3 was associated with epithelial-mesenchymal transition (EMT) signatures. Gain-of-function and loss-of-function experiments demonstrated that expression of SNAI1, the master regulator of EMT, was regulated by TYRO3 and played a major role in mediating TYRO3-induced EMT processes. The murine model also demonstrated that Tyro3 and Snai1 were upregulated in the early stage of colon cancer development. To provide a proof-of-concept that TYRO3 is a druggable target in colon cancer therapy, we raised anti-TYRO3 human antibodies and showed that treatment with the human antibody abolished TYRO3-induced EMT process. More importantly, administration of this anti-TYRO3 antibody increased drug sensitivity in primary cultured colon cancer cells and xenografted mouse tumors. These findings demonstrate that TYRO3 is a novel oncogene and a druggable target in colon cancer.

journal_name

Oncogene

journal_title

Oncogene

authors

Chien CW,Hou PC,Wu HC,Chang YL,Lin SC,Lin SC,Lin BW,Lee JC,Chang YJ,Sun HS,Tsai SJ

doi

10.1038/onc.2016.120

subject

Has Abstract

pub_date

2016-11-10 00:00:00

pages

5872-5881

issue

45

eissn

0950-9232

issn

1476-5594

pii

onc2016120

journal_volume

35

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • 5-aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1.

    abstract：:Observations that genome-wide DNA hypomethylation induces genome instability and tumors in animals caution against the indiscriminate use of demethylating agents, such as 5-aza-2'-deoxycytidine (5-Aza-dC). Using primary mouse embryonic fibroblasts harboring a lacZ mutational reporter construct that allows the quantifi...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2012.9

    authors： Maslov AY,Lee M,Gundry M,Gravina S,Strogonova N,Tazearslan C,Bendebury A,Suh Y,Vijg J

    更新日期：2012-12-13 00:00:00

  • Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3.

    abstract：:Hedgehog (Hh) is an oncogenic signaling pathway that regulates the activity of Gli transcription factors. Canonical Hh is a Smoothened- (Smo-) driven process that alters the post-translational processing of Gli2/Gli3 proteins. Though evidence supports a role for Gli action in prostate cancer (PCa) cell growth and prog...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-017-0098-7

    authors： Li N,Truong S,Nouri M,Moore J,Al Nakouzi N,Lubik AA,Buttyan R

    更新日期：2018-04-01 00:00:00

  • Uracil in DNA--occurrence, consequences and repair.

    abstract：:Uracil in DNA results from deamination of cytosine, resulting in mutagenic U : G mispairs, and misincorporation of dUMP, which gives a less harmful U : A pair. At least four different human DNA glycosylases may remove uracil and thus generate an abasic site, which is itself cytotoxic and potentially mutagenic. These e...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/sj.onc.1205996

    authors： Krokan HE,Drabløs F,Slupphaug G

    更新日期：2002-12-16 00:00:00

  • Cholecystokinin-2 receptor modulates cell adhesion through beta 1-integrin in human pancreatic cancer cells.

    abstract：:Several lines of evidence suggest that gastrin and the CCK-2 receptor (CCK2R) could contribute to pancreatic carcinogenesis by modulating processes such as proliferation, cell adhesion or migration. In the current study, we used a 'cancer gene array' and identified beta1-integrin subunit as a new gastrin-regulated gen...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1209484

    authors： Cayrol C,Clerc P,Bertrand C,Gigoux V,Portolan G,Fourmy D,Dufresne M,Seva C

    更新日期：2006-07-27 00:00:00

  • The path to metastatic mouse models of colorectal cancer.

    abstract：:The study and comprehension of the molecular mechanisms underlying cancer biology strongly rely on mouse modeling. An ideal mouse model should have molecular, histopathological, and etiological characteristics as close as possible to those of the corresponding human tumors. Among solid tumors, colorectal cancer (CRC) ...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/s41388-018-0155-x

    authors： Romano G,Chagani S,Kwong LN

    更新日期：2018-05-01 00:00:00

  • Ras-independent activation of Rel-family transcription factors by UVB and TPA in cultured keratinocytes.

    abstract：:UV irradiation of mammalian cells results in the activation of transcription factors which mediate induction of early response genes designed to repair and minimise the damage sustained by the cell. Evidence from studies in HeLa cells suggest that UVC regulates NF-kappa B activity via tyrosine kinases and activation o...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Tobin D,Nilsson M,Toftgård R

    更新日期：1996-02-15 00:00:00

  • Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.

    abstract：:The REL gene is amplified in many human B-cell lymphomas and we have previously shown that expression of REL from a retroviral vector can malignantly transform chicken spleen cells in vitro. To identify REL protein functions necessary for malignant transformation, we have performed deletion analysis on REL sequences e...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1206801

    authors： Starczynowski DT,Reynolds JG,Gilmore TD

    更新日期：2003-10-09 00:00:00

  • BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines.

    abstract：:BRAF mutations occur in ~10% of colorectal cancer (CRC) and are associated with poor prognosis. Inhibitors selective for the BRAFV600E oncoprotein, the most common BRAF mutant, elicit only poor response rates in BRAF-mutant CRC as single agents. This unresponsiveness was mechanistically attributed to the loss of negat...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-017-0063-5

    authors： Herr R,Halbach S,Heizmann M,Busch H,Boerries M,Brummer T

    更新日期：2018-03-01 00:00:00

  • Enhanced EGF mitogenic response is associated with enhanced tyrosine phosphorylation of specific cellular proteins in fibroblasts overexpressing c-src.

    abstract：:In previous studies examining the role of pp60c-src in cellular proliferation, we demonstrated that overexpression of wild type (wt) but not mutated c-src in C3H10T1/2 murine embryo fibroblasts resulted in a 2 to 5 fold enhancement of DNA synthesis in response to epidermal growth factor (EGF). Using phosphotyrosine an...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Wilson LK,Parsons SJ

    更新日期：1990-10-01 00:00:00

  • SYK interaction with ITGβ4 suppressed by Epstein-Barr virus LMP2A modulates migration and invasion of nasopharyngeal carcinoma cells.

    abstract：:Epstein-Barr virus (EBV)-encoded Latent Membrane Protein 2A (LMP2A) is an EBV latency-associated protein regularly expressed in nasopharyngeal carcinoma (NPC). In B cells, LMP2A activity resembles that of a constitutively activated antigen receptor, which recruits the Syk tyrosine kinase to activate a set of downstrea...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2014.380

    authors： Zhou X,Matskova L,Rathje LS,Xiao X,Gish G,Werner M,Ignatyev I,Yu N,Zhao W,Tian F,Hou B,Zhang Z,Pawson T,Chen F,Ernberg I

    更新日期：2015-08-20 00:00:00

  • The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair.

    abstract：:Loss of the DNA mismatch repair (MMR) protein MSH3 leads to the development of a variety of tumors in mice without significantly affecting survival rates, suggesting a modulating role for the MutSβ (MSH2-MSH3) complex in late-onset tumorigenesis. To better study the role of MSH3 in tumor progression, we crossed Msh3(-...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2013.365

    authors： van Oers JM,Edwards Y,Chahwan R,Zhang W,Smith C,Pechuan X,Schaetzlein S,Jin B,Wang Y,Bergman A,Scharff MD,Edelmann W

    更新日期：2014-07-24 00:00:00

  • Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse model.

    abstract：:Acute myeloid leukemia (AML) is a heterogeneous disease comprising a large number of subtypes defined by specific chromosome abnormalities. One such subtype carries the t(6;9)(p22;q34) chromosome rearrangement, which leads to expression of the DEK-NUP214 chimeric gene, and has a particularly poor outcome. To provide a...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2016.118

    authors： Qin H,Malek S,Cowell JK,Ren M

    更新日期：2016-10-27 00:00:00

  • PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia.

    abstract：:The p53 tumour suppressor is involved in several crucial cellular functions including cell-cycle arrest and apoptosis. p53 stabilization occurs under hypoxic and DNA damage conditions. However, only in the latter scenario is stabilized p53 capable of inducing the expression of its pro-apoptotic targets. Here we presen...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2008.192

    authors： Xenaki G,Ontikatze T,Rajendran R,Stratford IJ,Dive C,Krstic-Demonacos M,Demonacos C

    更新日期：2008-10-02 00:00:00

  • The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues.

    abstract：:We previously showed that the proto-oncogene RON encodes the tyrosine kinase receptor for Macrophage Stimulating Protein (MSP), originally isolated as a chemotactic factor for peritoneal macrophages. To elucidate the biological role of MSP we studied the expression of the Ron receptor in vivo, and the response to the ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Gaudino G,Avantaggiato V,Follenzi A,Acampora D,Simeone A,Comoglio PM

    更新日期：1995-12-21 00:00:00

  • LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms.

    abstract：:Lin28b is an RNA-binding protein that inhibits biogenesis of let-7 microRNAs. LIN28B is overexpressed in diverse cancers, yet a specific role in the molecular pathogenesis of colon cancer has to be elucidated. We have determined that human colon tumors exhibit decreased levels of mature let-7 isoforms and increased ex...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2011.131

    authors： King CE,Wang L,Winograd R,Madison BB,Mongroo PS,Johnstone CN,Rustgi AK

    更新日期：2011-10-06 00:00:00

  • Carcinoma of the vulva: HPV and p53 mutations.

    abstract：:Recent evidence suggests that squamous cell carcinoma of the vulva may have more than one etiology, with only some tumors associated with human papillomavirus (HPV). Cells infected with HPV produce a viral protein (E6) which binds to and causes rapid degradation of p53, possibly contributing to cellular transformation...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Lee YY,Wilczynski SP,Chumakov A,Chih D,Koeffler HP

    更新日期：1994-06-01 00:00:00

  • The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2.

    abstract：:PSP94, for prostatic secretory protein of 94 amino acids, is secreted by the prostate gland and functions as a suppressor of tumor growth and metastasis. The expression of PSP94 is lost in advanced, hormone-refractory prostate cancer and this correlates with an increased expression of the Polycomb protein EZH2 (enhanc...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1210248

    authors： Beke L,Nuytten M,Van Eynde A,Beullens M,Bollen M

    更新日期：2007-07-05 00:00:00

  • Prevalence and specificity of LKB1 genetic alterations in lung cancers.

    abstract：:Germline LKB1 mutations cause Peutz-Jeghers syndrome, a hereditary disorder that predisposes to gastrointestinal hamartomatous polyposis and several types of malignant tumors. Somatic LKB1 alterations are rare in sporadic cancers, however, a few reports showed the presence of somatic alterations in a considerable frac...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1210418

    authors： Matsumoto S,Iwakawa R,Takahashi K,Kohno T,Nakanishi Y,Matsuno Y,Suzuki K,Nakamoto M,Shimizu E,Minna JD,Yokota J

    更新日期：2007-08-30 00:00:00

  • Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells.

    abstract：:Somatic alterations of fibroblast growth factor receptors (FGFRs) have been described in a wide range of malignancies. A number of anti-FGFR therapies are currently under investigation in clinical trials for subjects with FGFR gene amplifications, mutations and translocations. Here, we develop cell line models of acqu...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2014.161

    authors： Wang J,Mikse O,Liao RG,Li Y,Tan L,Janne PA,Gray NS,Wong KK,Hammerman PS

    更新日期：2015-04-23 00:00:00

  • E2F-3 accumulation is regulated by polypeptide stability.

    abstract：:E2F is a complex family of transcription factors which appears to regulate the transcription of genes required for the S phase of the mammalian cell cycle. In the present work, we have examined the mechanisms regulating E2F-3 accumulation in mouse fibroblasts. We have determined that E2F-3 DNA binding activity is rest...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1201633

    authors： Flores AM,Kassatly RF,Cress WD

    更新日期：1998-03-12 00:00:00

  • MET targeting: time for a rematch.

    abstract：:MET, the receptor tyrosine kinase (RTK) for hepatocyte growth factor, is a proto-oncogene involved in embryonic development and throughout life in homeostasis and tissue regeneration. Deregulation of MET signaling has been reported in numerous malignancies, prompting great interest in MET targeting for cancer therapy....

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/s41388-020-1193-8

    authors： Koch JP,Aebersold DM,Zimmer Y,Medová M

    更新日期：2020-04-01 00:00:00

  • Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells.

    abstract：:Death receptor 5 (DR5) is a receptor for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). TRAIL is a promising candidate for cancer therapeutics due to its ability to induce apoptosis selectively in cancer cells. Here, we report that histone deacetylase inhibitors (HDACIs) such as trichostatin A (TSA),...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1207830

    authors： Nakata S,Yoshida T,Horinaka M,Shiraishi T,Wakada M,Sakai T

    更新日期：2004-08-19 00:00:00

  • MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway.

    abstract：:Glioma stem cells (GSCs) decrease T cells cognition and evade systemic immunosurveillance via downregulations or defects of major histocompatibility complex class I (MHC-I) molecule and antigen-processing machinery (APM) components. Improvement of tumor surface antigens of GSCs may be effective strategy to trigger an ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-019-1045-6

    authors： Yang W,Li Y,Gao R,Xiu Z,Sun T

    更新日期：2020-01-01 00:00:00

  • Differential modulation of Myb family genes by Ets-2.

    abstract：:The myb family of genes encodes highly homologous nuclear transcription factors that play distinct roles in the development of breast, germ cells and hematoid organs. While the mechanisms associated with the regulation of these genes remain unknown, the transactivation of c-Myb was previously shown to be upregulated b...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1207537

    authors： Kang AD,Park G,Kim YH,Oh IH

    更新日期：2004-05-20 00:00:00

  • Hypothesis: a novel route for immortalization of epithelial cells by Epstein-Barr virus.

    abstract：:Transfection of primate tissue explants with a specific sub-fragment (p31) of EBV DNA results in epithelial (but no other) cells proliferating indefinitely (becoming 'immortalized') without evidence of a 'growth crisis'. Molecular evidence supports integration of viral information into the host chromosome, and an earl...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1205130

    authors： Gao Y,Lu YJ,Xue SA,Chen H,Wedderburn N,Griffin BE

    更新日期：2002-01-24 00:00:00

  • Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours.

    abstract：:The naevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by multiple developmental defects and cancer susceptibility, in particular to basal cell carcinomas (BCCs). Medulloblastomas, primitive neuroectodermal tumours (PNETs) arising in childhood, occur in about 3-5% of NBCCS pa...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1201340

    authors： Vorechovský I,Tingby O,Hartman M,Strömberg B,Nister M,Collins VP,Toftgård R

    更新日期：1997-07-17 00:00:00

  • Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy.

    abstract：:Heat shock protein 90 (Hsp90) is a survival signaling chaperone and a cancer chemotherapeutic target. However, we have found that inhibitors of Hsp90 diminished the apoptotic response induced in leukemic cells by the antitumor alkyl-lysophospholipid analog edelfosine, which acts through lipid raft reorganization. Edel...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1210816

    authors： Nieto-Miguel T,Gajate C,González-Camacho F,Mollinedo F

    更新日期：2008-03-13 00:00:00

  • Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals.

    abstract：:Resistance to detachment-induced apoptosis, a process commonly referred as anoikis, is emerging as a hallmark of metastatic malignancies, mainly because it can ensure anchorage-independent growth and survival during organ colonization. Besides, a sustained oxidative stress has been associated with several steps of car...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2009.77

    authors： Giannoni E,Fiaschi T,Ramponi G,Chiarugi P

    更新日期：2009-05-21 00:00:00

  • THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.

    abstract：:Promyelocytic leukemia (PML) nuclear bodies (PML NBs) are discrete subnuclear domains organized by the promyelocytic leukemia protein PML, a tumor suppressor essential for multiple apoptotic pathways. We have recently described a novel family of cellular factors, the THAP proteins, characterized by the presence at the...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1206271

    authors： Roussigne M,Cayrol C,Clouaire T,Amalric F,Girard JP

    更新日期：2003-04-24 00:00:00

  • FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.

    abstract：:In this study, we investigated the regulation of FOXM1 expression by estrogen receptor alpha (ERalpha) and its role in hormonal therapy and endocrine resistance. FOXM1 protein and mRNA expression was regulated by ER-ligands, including estrogen, tamoxifen (OHT) and fulvestrant (ICI182780; ICI) in breast carcinoma cell ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2010.47

    authors： Millour J,Constantinidou D,Stavropoulou AV,Wilson MS,Myatt SS,Kwok JM,Sivanandan K,Coombes RC,Medema RH,Hartman J,Lykkesfeldt AE,Lam EW

    更新日期：2010-05-20 00:00:00